Schneider-Futschik EK - Search Results

1

Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation.

McQuade RM, Bandara M, Diwakarla S, Sahakian L, Han MN, Al Thaalibi M, Di Natale MR, Tan M, Harwood KH, Schneider-Futschik EK, Jarnicki A. McQuade RM, et al. Among authors: schneider futschik ek. Inflamm Res. 2023 Jan;72(1):57-74. doi: 10.1007/s00011-022-01657-0. Epub 2022 Nov 2. Inflamm Res. 2023. PMID: 36322182 Free PMC article.

2

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.

Harwood KH, McQuade RM, Jarnicki A, Schneider-Futschik EK. Harwood KH, et al. Int J Mol Sci. 2021 Jul 16;22(14):7606. doi: 10.3390/ijms22147606. Int J Mol Sci. 2021. PMID: 34299226 Free PMC article. Review.

3

Ivacaftor Alters Macrophage and Lymphocyte Infiltration in the Lungs Following Lipopolysaccharide Exposure.

Harwood KH, McQuade RM, Jarnicki A, Schneider-Futschik EK. Harwood KH, et al. ACS Pharmacol Transl Sci. 2022 Jun 10;5(6):419-428. doi: 10.1021/acsptsci.2c00007. eCollection 2022 Jun 10. ACS Pharmacol Transl Sci. 2022. PMID: 35711814 Free PMC article.

4

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis.

Hanafin PO, Sermet-Gaudelus I, Griese M, Kappler M, Ellemunter H, Schwarz C, Wilson J, Tan M, Velkov T, Rao GG, Schneider-Futschik EK. Hanafin PO, et al. Front Pharmacol. 2021 Aug 2;12:577263. doi: 10.3389/fphar.2021.577263. eCollection 2021. Front Pharmacol. 2021. PMID: 34408649 Free PMC article.

5

Entry of cystic fibrosis transmembrane conductance potentiator ivacaftor into the developing brain and lung.

Qiu F, Habgood MD, Huang Y, Dziegielewska KM, Toll S, Schneider-Futschik EK. Qiu F, et al. J Cyst Fibros. 2021 Sep;20(5):857-864. doi: 10.1016/j.jcf.2021.06.005. Epub 2021 Jun 27. J Cyst Fibros. 2021. PMID: 34193363 Free article.

6

In Utero Mapping and Development Role of CFTR in Lung and Gastrointestinal Tract of Cystic Fibrosis Patients.

Li D, Han X, Habgood M, Schneider-Futschik EK. Li D, et al. Among authors: schneider futschik ek. ACS Pharmacol Transl Sci. 2023 Feb 13;6(3):355-360. doi: 10.1021/acsptsci.2c00233. eCollection 2023 Mar 10. ACS Pharmacol Transl Sci. 2023. PMID: 36926454 Free PMC article. Review.

7

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis.

Han X, Li D, Reyes-Ortega F, Schneider-Futschik EK. Han X, et al. Among authors: schneider futschik ek. Pharmaceutics. 2023 May 13;15(5):1488. doi: 10.3390/pharmaceutics15051488. Pharmaceutics. 2023. PMID: 37242730 Free PMC article. Review.

8

The impact of backbone N-methylation on the structure-activity relationship of Leu₁₀ -teixobactin.

Velkov T, Swarbrick JD, Hussein MH, Schneider-Futschik EK, Hoyer D, Li J, Karas JA. Velkov T, et al. J Pept Sci. 2019 Sep;25(9):e3206. doi: 10.1002/psc.3206. Epub 2019 Aug 6. J Pept Sci. 2019. PMID: 31389086

9

Chronic Lung and Respiratory Conditions Affecting Lungs and Airways.

Schneider-Futschik EK. Schneider-Futschik EK. ACS Pharmacol Transl Sci. 2022 Aug 22;5(9):692-693. doi: 10.1021/acsptsci.2c00138. eCollection 2022 Sep 9. ACS Pharmacol Transl Sci. 2022. PMID: 36110373 Free PMC article. No abstract available.

10

Molecular Mechanisms of Neurotoxicity Induced by Polymyxins and Chemoprevention.

Dai C, Xiao X, Li J, Ciccotosto GD, Cappai R, Tang S, Schneider-Futschik EK, Hoyer D, Velkov T, Shen J. Dai C, et al. ACS Chem Neurosci. 2019 Jan 16;10(1):120-131. doi: 10.1021/acschemneuro.8b00300. Epub 2018 Nov 7. ACS Chem Neurosci. 2019. PMID: 30362702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page